Friday, Jun 6 2025 | Time 11:51 Hrs(IST)
Business Economy


Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection

Hyderabad, June 4 (UNI) The city based Gland Pharma on Wednesday announced receiving the approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Angiotensin II Acetate Injection 2.5 mg/ML.
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), GIAPREZA ® of La Jolla Pharma LLC, the Hyderabad based Pharma company said in a release here.
This Product is indicated for increasing the blood pressure in adults with septic or other distributive shock.
Gland Pharma is the exclusive First-to-File and is eligible for 180 days of generic drug exclusivity.
According to IQVIA, the product had US sales of approximately USD 58 million for the twelve months ending March 2025.
UNI KNR BM
More News
Sensex down by 113 65 points

Sensex down by 113 65 points

06 Jun 2025 | 10:08 AM

Mumbai, June 6 (UNI) The BSE Sensex on Friday fell by 113.65 pts to 81,328.39 in early trade tracking negative cues from Asian peers.

see more..

On World Environment Day, Singareni announces complete ban on plastic usage

06 Jun 2025 | 12:38 AM

Hyderabad, June 5 (UNI) On the occasion of World Environment Day, with the global theme 'Let’s put an end to plastic pollution globally', state-owned Singareni Collieries Company Limited (SCCL) on Thursday declared a complete ban on plastic usage across all its areas, including the Hyderabad office.

see more..

RIR Power Electronics expands SiC diode production

05 Jun 2025 | 10:20 PM

New Delhi, June 5 (UNI) In a significant step towards bolstering India’s indigenous semiconductor capabilities, RIR Power Electronics Ltd. on Thursday announced the successful expansion of its 1200V Silicon Carbide (SiC) diode production through a strategic collaboration with Taiwan-based Pro Asia Semiconductor Corporation (PASC).

see more..

Dr Reddy’s Lab partners with Alvotech to Co-Develop & commercialize Biosimilar Candidate

05 Jun 2025 | 10:15 PM

Hyderabad, June 5 (UNI) Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Hyderabad-based Dr. Reddy’s Laboratories Ltd, on Thursday announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets.

see more..

USBRL Project: Historic milestone for J&K, says Jammu ICC Chairman, hails PM Modi

05 Jun 2025 | 7:57 PM

Jammu, June 5 (UNI) Chairman of the Indian Chamber of Commerce (ICC), Jammu, Rahul Sahai on Thursday hailed the visionary leadership of Prime Minister Narendra Modi for inaugurating the much-awaited train service to Kashmir terming it a moment that marks a historic turning point in the development journey of Jammu and Kashmir.

see more..